EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid

online resource

posted on 2024-03-08, 18:02 authored by Amanda Brennan, Daniel Chang, John Cowden, Sarah Davidson-Fritz, Jeffry Dean, Michael Devito, Jermaine Ford, Logan Everett, Alison Harrill, Susan Hester, Michael Hughes, Jason Lambert, Lucina Lizarraga, Roman Mezencev, Denise MacMillan, Grace Patlewicz, Kristina Chialton, Russell Thomas, Kelsey Vitense, Leah Wehmas, Aero Renyer, Scott Auerbach, Warren Casey

The EPA Transcriptomic Assessment Product (ETAP) is a human health assessment that utilizes a standardized short-term in vivo study design and data analysis procedures to develop transcriptomic-based reference values for data poor chemicals. The reference value represents the daily dose of the chemical that would likely be without appreciable risk to human health over a lifetime. This dataset corresponds to the transcriptomic studies on perfluoro-3-methoxypropanoic acid (DTXSID70191136). More information about ETAP is available at: https://www.epa.gov/etap.

Science Inventory, CCTE products: https://cfpub.epa.gov/si/si_public_search_results.cfm?advSearch=true&showCriteria=2&keyword=CCTE&TIMSType=&TIMSSubTypeID=&epaNumber=&ombCat=Any&dateBeginPublishedPresented=07/01/2017&dateEndPublishedPresented=&dateBeginUpdated=&dateEndUpdated=&DEID=&personName=&personID=&role=Any&journalName=&journalID=&publisherName=&publisherID=&sortBy=pubDate&count=25